Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
Sanderling Ventures
AddedFeb 13, 2024
UpdatedJun 28, 2026
Sanderling Ventures

Sanderling Ventures

Operating

Sanderling Ventures: A venture capital firm investing in biotech, healthcare, and medical sectors in the US and Canada.

Location
San Mateo, CA, US
Founded
1979
Firm
Compare
Portfolio
Employees
Website

Sanderling Ventures is a venture capital firm focusing on investments in biotechnology, therapeutics, pharmaceuticals, medical devices, and healthcare sectors. The firm primarily operates in the United States and Canada, with typical investment rounds including Series A, B, C, D, and later stages. Sanderling Ventures has a broad investment range, participating in various funding rounds to support the growth and development of innovative healthcare companies.

Notable portfolio companies include Chimerix, Dynavax Technologies, Glycomine, Metavention, and ViaCyte. Key partners and decision-makers at Sanderling Ventures bring extensive industry experience and networks to the table, providing strategic guidance and support to their portfolio companies. The firm’s investment philosophy emphasizes fostering groundbreaking advancements in healthcare through substantial financial backing and value-added services such as mentorship, industry connections, and operational expertise.

Sanderling Ventures - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments45
Current Portfolio Count18
Total Portfolio Exits2

Top Investment Stages

Series A11 (26.2%)
Series B10 (23.8%)
Series C8 (19.0%)
Series Unknown7 (16.7%)
Series D6 (14.3%)

Stage Mix

Series A 26%Series B 24%Series C 19%Series Unknown 17%Series D 14%

Concentration shown as share of disclosed investments by stage.

Recent Investments

Glycomine logo

Glycomine

ViaCyte logo

ViaCyte

Metavention logo

Metavention

Sotera Wireless logo

Sotera Wireless

Theravida logo

Theravida

Chimerix logo

Chimerix

Trinity Biosystems logo

Trinity Biosystems

Novostent logo

Novostent

Axikin Pharmaceuticals logo

Axikin Pharmaceuticals

Asteres logo

Asteres

Naviscan logo

Naviscan

Cylene Pharmaceuticals logo

Cylene Pharmaceuticals

Xytis logo

Xytis

Tomophase logo

Tomophase

Artielle ImmunoTherapeutics logo

Artielle ImmunoTherapeutics

Kadmus Pharmaceuticals logo

Kadmus Pharmaceuticals

CyThera logo

CyThera

Dynavax Technologies logo

Dynavax Technologies

Genteric logo

Genteric

BioSpace logo

BioSpace

Net32 logo

Net32

Sanderling Ventures - Classification

Also Known As
  • Sanderling Management Company, LLC
NAICS
  • 520000Finance and Insurance
  • 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
  • 523900Other Financial Investment Activities
  • 523990All Other Financial Investment Activities
  • 523999Miscellaneous Financial Investment Activities
SIC
  • 6700Holding And Other Investment Offices
  • 6790Miscellaneous Investing
  • 6799Investors, Not Elsewhere Classified
ISIC
  • 6499Other financial service activities, except insurance and pension funding activities, n.e.c.
  • 7490Other professional, scientific and technical activities n.e.c.
Show 18 more industry codes
NAICS
  • 523100Securities and Commodity Contracts Intermediation and Brokerage
  • 523150Investment Banking and Securities Intermediation
  • 540000Professional, Scientific, and Technical Services
  • 541690Other Scientific and Technical Consulting Services
  • 525000Funds, Trusts, and Other Financial Vehicles
  • 541000Professional, Scientific, and Technical Services
  • 541600Management, Scientific, and Technical Consulting Services
  • 523910Miscellaneous Intermediation
  • 523940Portfolio Management and Investment Advice
SIC
  • 6210Security Brokers, Dealers, And Flotation Companies
  • 6211Security Brokers, Dealers, And Flotation Companies
  • 8900Services, Not Elsewhere Classified
  • 8990Services, Not Elsewhere Classified
  • 8999Services, Not Elsewhere Classified
  • 6000Depository Institutions
  • 6200Security And Commodity Brokers, Dealers, Exchanges, And Services
  • 6720Investment Offices
  • 6722Management Investment Offices, Open-end